Share on StockTwits

Greenlight Capital Re (NASDAQ:GLRE) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a note issued to investors on Monday. They currently have a $37.00 price target on the stock. Zacks‘s target price would indicate a potential upside of 11.18% from the stock’s previous close.

Greenlight Capital Re (NASDAQ:GLRE) traded up 0.04% during mid-day trading on Monday, hitting $33.2925. The stock had a trading volume of 67,626 shares. Greenlight Capital Re has a 52 week low of $26.70 and a 52 week high of $34.93. The stock’s 50-day moving average is $33.40 and its 200-day moving average is $32.4. The company has a market cap of $1.242 billion and a P/E ratio of 5.20.

Greenlight Capital Re (NASDAQ:GLRE) last announced its earnings results on Monday, August 4th. The company reported $2.89 earnings per share for the quarter, missing the analysts’ consensus estimate of $3.04 by $0.15. During the same quarter last year, the company posted $0.76 earnings per share. Analysts expect that Greenlight Capital Re will post $4.37 EPS for the current fiscal year.

In other Greenlight Capital Re news, Director Leonard R. Goldberg sold 7,929 shares of the company’s stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $32.65, for a total transaction of $258,881.85. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

GLRE has been the subject of a number of other recent research reports. Analysts at Keefe, Bruyette & Woods cut their price target on shares of Greenlight Capital Re from $40.00 to $39.00 in a research note on Wednesday, August 6th.

Greenlight Capital Re, Ltd. (NASDAQ:GLRE) is a holding company.

To view Zacks’ full report, visit Zacks’ official website.

Receive News & Ratings for Greenlight Capital Re Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenlight Capital Re Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.